Principal Investigator: Dr. Mark Basik Associate Professor of Surgery and Oncology, Surgical Oncologist
A Simple Blood Test Could Help Change the Future of Breast Cancer Care
Dr. Mark Basik and his team are exploring how liquid biopsies, biomarkers, and cancer genomics can help doctors detect cancer-related changes earlier, monitor treatment response in real time, and personalize care for patients.
Dr. Mark Basik
McGill Centre for Translational Research in Cancer Senior Investigator, Lady Davis Institute for Medical Research
Associate Professor, Departments of Surgery and Oncology, McGill University
Dr. Basik’s research program is the identification of amplified and over expressed genes in primary, metastatic or anti-cancer treatment resistant breast cancers.
Breast cancer is the is the 2nd leading cause of death from cancer in women living in Canada.
On average, 89 women in Canada will be diagnosed with breast cancer every day
What if a simple blood test could detect the earliest signs of breast cancer before it can be seen, felt, or has the chance to return?
Dr. Mark Basik and his team are exploring how liquid biopsies, biomarkers, and cancer genomics can help doctors detect cancer-related changes earlier, monitor treatment response in real time, and personalize care for patients.
Potential Impact
- Earlier detection of recurrence and disease progression
- Less invasive testing and fewer biopsies
- Better access to monitoring for patients in rural communities
- Faster treatment adjustments based on real-time results
- More personalized care for metastatic and triple-negative breast cancer patients
By analyzing cancer DNA found in the blood, this research could help doctors identify treatment resistance sooner, predict recurrence risk, and make more informed treatment decisions.
CURE Foundation is proud to support Dr. Mark Basik's innovative research and its potential to improve breast cancer detection, monitoring, and treatment for Canadians.
Our Researchers & Funding Partners
Providing financial support for breast cancer research has always been a driving force in CURE’s mission. Through strategic partnerships with Canada’s top institutions, the foundation invests in basic, translational and clinical research, all with the goal of improving treatment and finding a cure.
